期刊
KARDIOLOGIA POLSKA
卷 79, 期 3, 页码 287-293出版社
POLSKIE TOWARZYSTOWO KARDIOLOGICZNE
DOI: 10.33963/KP.15812
关键词
patent ductus arteriosus; percutaneous intervention; treatment outcome
资金
- Medical University of Silesia [KNW-2-K15/D/8/N]
Transcatheter closure of patent ductus arteriosus with various devices is safe and effective, with high success rates and significant outcomes after 1 year. ADO II AS has replaced coils as the preferred device for closing small-to-moderate PDA.
BACKGROUND Transcatheter patent ductus arteriosus (PDA) closure has become the first-choice method of treatment in the majority of patients. However, device selection poses a challenge. AIMS This study aimed to analyze periprocedural and 1-year outcomes of PDA transcatheter closure performed with different devices throughout a 25-year time period in a single center. METHODS All 1036 patients who underwent transcatheter PDA closure between 1993 and 2020 were included in retrospective analysis. Various devices were used: the Rashkind device ( RD; n = 25), coils (n = 469), nitinol duct occluders type I (DO I; n = 300), type II (n = 32), type II additional sizes (ADO II AS; n = 209), as well as off-label devices: vascular plugs and atrial septal and muscular ventricular septal defect occluders (n = 17). Data on 24-hour and 1-year follow-up were available for 100% and 78.9% of the study patients, respectively. RESULTS The procedure was successful in 98.6% of the study patients, with a major complication rate of 0.2%. Complete PDA closure after a year was observed in 81.8% of the patients treated with RD, 93.7% of those with coils, and 100% of those with duct occluders. There were no differences between Amplatzer DO I (n = 159) and its DO I copies manufactured in China (n = 141) with regard to success, efficacy, and complication rates. Recently, ADO II AS has replaced coils and become the preferred device to close small-to-moderate PDA. CONCLUSIONS Transcatheter PDA closure with all types of nitinol duct occluders is safe and effective, with no residual shunting at 1-year follow-up. Due to higher efficacy, ADO II AS has replaced coils in the treatment of smaller PDA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据